Treatment with antidepressants or with mGlu5 antagonist MTEP was studied in rats.
The mGlu5 receptor binding and/or mGlu5 protein level was evaluated brain structures.
Increase in mGlu5 receptor Bmax and/or expression was found in cortex/hippocampus.
The mGlu5 receptors may represent a target for antidepressant therapy.